References
- AydemirCDeveciATaneliF2005The effect of chronic antidepressant treatment of serum brain-derived neurotrophic factor levels in depressed patients: a preliminary studyProg Neuropsychopharmacol Biol Psychiatry29261515694233
- ChanCHJanicakPGDavisJM1987Response of psychotic and non-psychotic depressed patients to tricyclic antidepressantsJ Clin Psychiatry481972003571174
- CharneyDSNelsonJC1981Delusional depression and nondelusional unipolar depressionAm J psychiatry138328336110345
- DurmanRSHeningerGRNestlerEJ1997A molecular and cellular theory of depressionArch Gen Psychiatry545976059236543
- EbertD1997Lithium-TCA combination treatment of psychotic depression: comparison with TCA-neuroleptic treatmentJ Clin Psychopharmacol171293010950483
- GotoMYoshimuraRKakiharaS2006Risperidone in the treatment of psychotic depressionProg Neuropsychopharmacol Biol Psychiatry30701716580110
- GonulASAkdenizFTaneliF2005Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patientsEur Arch Psychiatry Clin Neurosci255381615809771
- GuptaRN1994Column liquid chromatographic detection of paroxetine in human serum using solid-phase extractionJ Chromatgr6613625
- KaregeFPerretGBondolfiG2002Decreased serum brain-derived neurotrophic factor levels in major depressed patientsPsychiatry Res109143811927139
- KaregeFBondolfiGGervasoniN2005Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivityBiol Psychiatry4710687215860348
- LangUEHellwegRGallinatJ2004BDNF serum concentrations in healthy volunteers are associated with depression-related personality traitsNeuropsychopharmacol297958
- LenoxRHManjiHKSchtzbergAFNemeroffCB1998Lithium Textbook of Psychopharmacology2nd editionAmerican Psychiatric PressWashington D.C379429
- MatthewsJDBottonariKAPolaniaLM2002An open study of olanzapine and fluoxetine for psychotic major depressive disorder: interim analysisJ Clin Psychiatry6311647012523877
- NelsonJCBowersMBJ1978Delusional unipolar depression: description and drug responseArch Gen Psychiatry3513212830427
- ShimizuEHashimotoKOkumaN2003Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressantsBiol Psychiatry54707512842310
- ShovalGWeizmanA2005The possible role of neurotrophins in the pathogenesis and theory of schizophreniaEur Neuropsychopharmacol153192915820422
- TeraoTYanagiharaNAbeK1992Lithium chloride stimulates catecholamine synthesis and secretion in cultured bovine adrenal medullary cellsBiol Psychiatry311038491354987
- TeraoTNakamuraJYoshimuraR2000Prediction of lithium response using m-chlorphenylpiperazine challenge test: a preliminary findingInt Clin Psychopharmacol15394210836285
- YoshimuraRMitomaMSugitaA2007Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patientsProg Neuropsychopharmacol Biol Psychiatry3110343717459550
- YukimasaTYoshimuraRTamagawaA2006High-frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factorsPharmacopsychiatry3952916555165
- ZullinoDBaumannPLithium augmentation in depressive patients not responding to selective serotonin reuptake inhibitorsPharmacopsychiatry341192711518471